Literature DB >> 11093914

Nonhepatic response to portal glucose delivery in conscious dogs.

M C Moore1, P S Hsieh, D W Neal, A D Cherrington.   

Abstract

The glycemic and hormonal responses and net hepatic and nonhepatic glucose uptakes were quantified in conscious 42-h-fasted dogs during a 180-min infusion of glucose at 10 mg. kg(-1). min(-1) via a peripheral (Pe10, n = 5) or the portal (Po10, n = 6) vein. Arterial plasma insulin concentrations were not different during the glucose infusion in Pe10 and Po10 (37 +/- 6 and 43 +/- 12 microU/ml, respectively), and glucagon concentrations declined similarly throughout the two studies. Arterial blood glucose concentrations during glucose infusion were not different between groups (125 +/- 13 and 120 +/- 6 mg/dl in Pe10 and Po10, respectively). Portal glucose delivery made the hepatic glucose load significantly greater (36 +/- 3 vs. 46 +/- 5 mg. kg(-1). min(-1) in Pe10 vs. Po10, respectively, P < 0.05). Net hepatic glucose uptake (NHGU; 1.1 +/- 0. 4 vs. 3.1 +/- 0.4 mg. kg(-1). min(-1)) and fractional extraction (0. 03 +/- 0.01 vs. 0.07 +/- 0.01) were smaller (P < 0.05) in Pe10 than in Po10. Nonhepatic (primarily muscle) glucose uptake was correspondingly increased in Pe10 compared with Po10 (8.9 +/- 0.4 vs. 6.9 +/- 0.4 mg. kg(-1). min(-1), P < 0.05). Approximately one-half of the difference in NHGU between groups could be accounted for by the difference in hepatic glucose load, with the remainder attributable to the effect of the portal signal itself. Even in the absence of somatostatin and fixed hormone concentrations, the portal signal acts to alter partitioning of a glucose load among the tissues, stimulating NHGU and reducing peripheral glucose uptake.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093914     DOI: 10.1152/ajpendo.2000.279.6.E1271

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  11 in total

1.  The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing.

Authors:  Fabien Delaere; Adeline Duchampt; Lourdes Mounien; Pascal Seyer; Céline Duraffourd; Carine Zitoun; Bernard Thorens; Gilles Mithieux
Journal:  Mol Metab       Date:  2012-12-07       Impact factor: 7.422

2.  Effect of portal glucose sensing on incretin hormone secretion in a canine model.

Authors:  Dale S Edgerton; Guillaume Kraft; Marta S Smith; Lindsey M Moore; Ben Farmer; Melanie Scott; Mary C Moore; Michael A Nauck; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-05-21       Impact factor: 4.310

3.  Chronic parenteral nutrition induces hepatic inflammation, steatosis, and insulin resistance in neonatal pigs.

Authors:  Barbara Stoll; David A Horst; Liwei Cui; Xiaoyan Chang; Kenneth J Ellis; Darryl L Hadsell; Agus Suryawan; Ashish Kurundkar; Akhil Maheshwari; Teresa A Davis; Douglas G Burrin
Journal:  J Nutr       Date:  2010-10-27       Impact factor: 4.798

4.  Morning Hyperinsulinemia Primes the Liver for Glucose Uptake and Glycogen Storage Later in the Day.

Authors:  Mary Courtney Moore; Marta S Smith; Ben Farmer; Katie C Coate; Guillaume Kraft; Masakazu Shiota; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2018-04-17       Impact factor: 9.461

5.  Portal glucose delivery stimulates muscle but not liver protein metabolism.

Authors:  Guillaume Kraft; Katie C Coate; Dominique Dardevet; Ben Farmer; E Patrick Donahue; Phillip E Williams; Alan D Cherrington; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-25       Impact factor: 4.310

6.  Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.

Authors:  Mary Courtney Moore; Kazuhiro Kimura; Haruki Shibata; Tsutomu Honjoh; Masayuki Saito; Carrie A Everett; Marta S Smith; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-03-08       Impact factor: 4.310

7.  Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine.

Authors:  Dale S Edgerton; Alan D Cherrington; Doss W Neal; Melanie Scott; Margaret Lautz; Nancy Brown; Jeff Petro; Charles H Hobbs; Chet Leach; Angelo Del Parigi; Thomas R Strack
Journal:  J Pharmacol Exp Ther       Date:  2008-12-19       Impact factor: 4.030

8.  A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin.

Authors:  Jason J Winnick; Zhibo An; Mary Courtney Moore; Christopher J Ramnanan; Ben Farmer; Masakazu Shiota; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-26       Impact factor: 4.310

9.  Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog.

Authors:  Dale S Edgerton; Kathryn M S Johnson; Doss W Neal; Melanie Scott; Charles H Hobbs; Xia Zhang; Alokesh Duttaroy; Alan D Cherrington
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

10.  Liver, but not muscle, has an entrainable metabolic memory.

Authors:  Sheng-Song Chen; Yolanda F Otero; Kimberly X Mulligan; Tammy M Lundblad; Phillip E Williams; Owen P McGuinness
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.